SCHEMBL21035284

SCHEMBL21035284

c1ccc(-c2ccc3c(c2)c2ccccc2c2c4ccc(-c5cccc6c(-c7cccc8oc9ccccc9c78)cccc56)cc4c4ccccc4c32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.42
PLA2G4A P47712 5/20 0.42
PLA2G10 O15496 1/20 0.40
ALOX5 P09917 1/20 0.39
PRKDC P78527 3/20 0.35
HPGD P15428 2/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
NPC1 O15118 1/20 0.35
TNKS O95271 1/20 0.35
TP53 P04637 1/20 0.35
ABCB1 P08183 1/20 0.35
CYP3A4 P08684 1/20 0.35
PARP1 P09874 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035288 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21034889 0.94 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21035285 0.94 ALOX5 (0.42) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21035287 0.93 ALOX5 (0.41) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL25081967 0.92 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21035286 0.92 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21034890 0.90 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL21035453 0.90 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL25140451 0.90 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10ALOX5PRKDC
SCHEMBL25140572 0.88 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10ALOX5PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 PLA2G2A 2960/4885PLA2G4A 2931/4885PLA2G10 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.